CRISPR Therapeutics AG - Common Stock (CRSP)

CUSIP: H17182108

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
95,714,968
Total 13F shares
72,232,014
Share change
-93,633
Total reported value
$4,681,196,062
Put/Call ratio
90%
Price per share
$64.81
Number of holders
435
Value change
+$29,481,399
Number of buys
216
Number of sells
175

Quarterly Holders Quick Answers

What is CUSIP H17182108?
CUSIP H17182108 identifies CRSP - CRISPR Therapeutics AG - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CRISPR Therapeutics AG - Common Stock (CRSP) as of Q3 2025

As of 30 Sep 2025, CRISPR Therapeutics AG - Common Stock (CRSP) was held by 435 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 72,232,014 shares. The largest 10 holders included ARK Investment Management LLC, BlackRock, Inc., Capital International Investors, Orbis Allan Gray Ltd, STATE STREET CORP, T. Rowe Price Investment Management, Inc., VANGUARD GROUP INC, UBS Group AG, Sumitomo Mitsui Trust Group, Inc., and Amova Asset Management Americas, Inc.. This page lists 435 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.